{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:13:35Z","timestamp":1778721215415,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":108,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"BBSRC","doi-asserted-by":"publisher","award":["BB\/R009775\/1"],"award-info":[{"award-number":["BB\/R009775\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010438","name":"The Francis Crick Institute","doi-asserted-by":"publisher","award":["FC001060"],"award-info":[{"award-number":["FC001060"]}],"id":[{"id":"10.13039\/100010438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ejmech.2022.114105","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T20:56:15Z","timestamp":1641848175000},"page":"114105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen)"],"prefix":"10.1016","volume":"230","author":[{"given":"Martyn","family":"Frederickson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8683-4131","authenticated-orcid":false,"given":"Irwin R.","family":"Selvam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0472-7576","authenticated-orcid":false,"given":"Dimitrios","family":"Evangelopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7193-5044","authenticated-orcid":false,"given":"Kirsty J.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona M.","family":"Katariya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0499-4113","authenticated-orcid":false,"given":"Richard B.","family":"Tunnicliffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3847-073X","authenticated-orcid":false,"given":"Bethany","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4735-1559","authenticated-orcid":false,"given":"Madeline E.","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4447-3438","authenticated-orcid":false,"given":"Sitthivut","family":"Charoensutthivarakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard T.","family":"Blankley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9724-310X","authenticated-orcid":false,"given":"Colin W.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Pedro S.","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Leys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew W.","family":"Munro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0205-5630","authenticated-orcid":false,"given":"Anthony G.","family":"Coyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Abell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114105_bib1","series-title":"Global Tuberculosis Report 2020","year":"2020"},{"key":"10.1016\/j.ejmech.2022.114105_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114105_bib3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.tim.2006.03.002","article-title":"The preponderance of P450s in the Mycobacterium tuberculosis genome","volume":"14","author":"McLean","year":"2006","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejmech.2022.114105_bib4","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1073\/pnas.0812191106","article-title":"Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis","volume":"106","author":"Belin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2022.114105_bib5","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1021\/ol300831t","article-title":"Total synthesis of mycocyclosin","volume":"14","author":"Cochrane","year":"2012","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2022.114105_bib6","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1021\/acs.orglett.8b00894","article-title":"Scalable synthesis of mycocyclosin","volume":"20","author":"Zhu","year":"2018","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2022.114105_bib7","doi-asserted-by":"crossref","first-page":"33406","DOI":"10.1074\/jbc.M802115200","article-title":"Characterization of active site structure in CYP121: a cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv","volume":"283","author":"McLean","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114105_bib8","doi-asserted-by":"crossref","first-page":"9311","DOI":"10.1002\/anie.201202544","article-title":"Application of fragment screening and merging to the discovery of the Mycobacterium tuberculosis cytochrome P450 CYP121","volume":"51","author":"Hudson","year":"2012","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2022.114105_bib9","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1021\/acs.jmedchem.6b00007","article-title":"Fragment-based approaches to the development of Mycobacterium tuberculosis CYP121 inhibitors","volume":"59","author":"Kavanagh","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114105_bib10","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/cmdc.201600248","article-title":"Substrate fragmentation for the design of M.\u00a0tuberculosis CYP121 inhibitors","volume":"11","author":"Kavanagh","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.114105_bib11","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1021\/acs.jmedchem.9b00304","article-title":"FragLites-Minimal, halogenated fragments displaying pharmacophore doublets. An efficient approach to druggability assessment and hit generation","volume":"62","author":"Wood","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114105_bib12","unstructured":"Cavallito, C.J.; Gray, A.P. Indolylethyl Pyridinium Quaternary Ammonium Compounds. US vol. 3,409,626."},{"key":"10.1016\/j.ejmech.2022.114105_bib13","unstructured":"Frederickson, M.; Gill, A.L.; Padova, A; Congreve, M.S. Pharmaceutical Compounds. WO 03\/087087 A2."},{"key":"10.1016\/j.ejmech.2022.114105_bib14","unstructured":"Tomoo, T.; Nakatsuka, T.; Hayashi, Y.; Katayama, T. Indole Derivative Having CPLA2 Inhibitory Activity, Use of the Same and Method for Producing the Same. WO 2008\/120818 A1."},{"key":"10.1016\/j.ejmech.2022.114105_bib15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1021\/jm00295a037","article-title":"1,4-Bis(2-indol-3-ylethyl)piperidines","volume":"13","author":"Archibald","year":"1970","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114105_bib16","unstructured":"Kuduk, S.D.; Liverton, N.; Luo, Y. Heteroaryl Orexin Receptor Antagonists. WO 2016\/100156 A1."},{"key":"10.1016\/j.ejmech.2022.114105_bib17","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.1021\/ja901416p","article-title":"A\u00a0general solution for unstable boronic acids: slow-release cross-coupling from air-stable MIDA boronates","volume":"131","author":"Knapp","year":"2009","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114105_bib18","doi-asserted-by":"crossref","first-page":"h4","DOI":"10.1021\/jm049575n","article-title":"Identification of novel p38 MAP kinase inhibitors using fragment-based lead generation","volume":"48","author":"Gill","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114105_bib19","unstructured":"Audiau, F.; Le Fur, G.R. ((T\u00e9tra- et hexahydro pyridyl-4)-2 \u00e9thyl)-3 indoles et leur utilisation comme m\u00e9dicaments. EP 0 065 907 B1."},{"key":"10.1016\/j.ejmech.2022.114105_bib20","doi-asserted-by":"crossref","first-page":"15818","DOI":"10.1021\/jacs.9b06275","article-title":"Water networks can determine the affinity of ligand binding to proteins","volume":"141","author":"Darby","year":"2019","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114105_bib21","series-title":"Phasentransfer-katalysierte N-sulfonierung von indol","first-page":"136","author":"Illi","year":"1979"},{"key":"10.1016\/j.ejmech.2022.114105_bib22","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/open.201900227","article-title":"Design and synthesis of imidazole and triazole pyrazoles as Mycobacterium tuberculosis CYP121A1 inhibitors","volume":"8","author":"Kishk","year":"2019","journal-title":"ChemistryOpen"},{"key":"10.1016\/j.ejmech.2022.114105_bib23","doi-asserted-by":"crossref","first-page":"10958","DOI":"10.1021\/jm301389h","article-title":"Potent, selective, and orally bioavailable inhibitors of the mammalian target of rapamycin kinase domain exhibiting single agent antiproliferative activity","volume":"55","author":"Koehler","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114105_bib24","unstructured":"Gopalsamy, A.; Shi, M.; Zask, A.; Venkatesan, A.M.; Curran, K.G. 5,6,7,8-Tetrahydropyrido[3,4-d]pyrimidine Compounds and Their Use as mTOR Kinase and PI3 Kinase Inhibitors, and Their Syntheses. WO 2010\/120996 A1."},{"key":"10.1016\/j.ejmech.2022.114105_bib25","unstructured":"Anderson, D.R.; Mahoney, M.W.; Phillion, D.P.; Rogers, T.E.; Meyers, M.J.; Poda, G.; Hedge, S.G.; Singh, M.; Reitz, D.B.; Wu, K.K.; Buchler, I.P.; Xie, J.; Vernier, W.F. Mitogen Activated Protein Kinase-Activated Protein Kinase-2 Inhibiting Compounds. WO 2004\/058762 A1."},{"key":"10.1016\/j.ejmech.2022.114105_bib26","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1021\/ol4013958","article-title":"Total synthesis of spirobacillene A","volume":"15","author":"Unsworth","year":"2013","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2022.114105_bib27","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1055\/s-0036-1591719","article-title":"Borane-catalysed hydroboration of alkynes and alkenes","volume":"50","author":"Ang","year":"2018","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2022.114105_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1021\/jm0495778","article-title":"Fragment-based lead discovery using X-ray crystallography","volume":"48","author":"Hartshorn","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114105_bib29","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.drudis.2019.03.009","article-title":"Crystallographic screening using ultra-low-molecular-weight ligands to guide drug design","volume":"24","author":"O'Reilly","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2022.114105_bib30","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1107\/S2052252519011655","article-title":"High-throughput structures of protein-ligand complexes at room temperature using serial femtosecond crystallography","volume":"6","author":"Moreno-Chicano","year":"2019","journal-title":"IuCrJ"},{"key":"10.1016\/j.ejmech.2022.114105_bib31","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1021\/acs.jmedchem.8b00172","article-title":"Identification of morpholino thiophenes as novel Mycobacterium tuberculosis inhibitors, targeting QcrB","volume":"61","author":"Cleghorn","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114105_bib32","doi-asserted-by":"crossref","first-page":"11327","DOI":"10.1021\/acs.jmedchem.8b01533","article-title":"Easy-to-synthesize spirocyclic compounds possess remarkable in\u00a0vivo activity against Mycobacterium tuberculosis","volume":"61","author":"Guardia","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114105_bib33","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1021\/acs.jmedchem.9b01561","article-title":"Mycobacterium tuberculosis Decaprenylphosphoryl-\u03b2-D-ribose Oxidase inhibitors: expeditious reconstruction of suboptimal hits into a series with potent in\u00a0vivo activity","volume":"63","author":"Borthwick","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114105_bib34","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1021\/acs.jmedchem.8b00777","article-title":"Indolyl azaspiroketal mannich bases are potent antimycobacterial agents with selective membrane permeabilizing effects and in\u00a0vivo activity","volume":"61","author":"Nyantakyi","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114105_bib35","doi-asserted-by":"crossref","first-page":"10586","DOI":"10.1021\/acs.jmedchem.9b01203","article-title":"Targeting of fumarate hydratase from Mycobacterium tuberculosis using allosteric inhibitors with a dimeric-binding mode","volume":"62","author":"Whitehouse","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114105_bib36","doi-asserted-by":"crossref","first-page":"10583","DOI":"10.1021\/acs.jmedchem.9b01716","article-title":"Changing the rules of TB-drug discovery","volume":"62","author":"Harrison","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114105_bib37","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1007\/s00253-019-09697-z","article-title":"Function, essentiality, and expression of cytochrome P450 enzymes and their cognate redox partners in Mycobacterium tuberculosis: are they drug targets?","volume":"103","author":"Ortega Ugalde","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejmech.2022.114105_bib38","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0162-0134(02)00479-8","article-title":"Expression, purification and spectroscopic characterization of the cytochrome P450 CYP121 from Mycobacterium tuberculosis","volume":"91","author":"McLean","year":"2002","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2022.114105_bib39","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1074\/jbc.M209928200","article-title":"Atomic structure of Mycobacterium tuberculosis CYP121 to 1.06 \u00c5 reveals novel features of cytochrome P450","volume":"278","author":"Leys","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114105_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1107\/S2059798317017235","article-title":"DIALS: implementation and evaluation of a new integration package","volume":"75","author":"Winter","year":"2018","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.ejmech.2022.114105_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.ejmech.2022.114105_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1107\/S0907444909047374","article-title":"Integration, scaling, space-group assignment and post-refinement","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.ejmech.2022.114105_bib43","first-page":"7","article-title":"Xtriage and Fest: automatic assessment of X-ray data and substructure structure factor estimation","volume":"43","author":"Zwart","year":"2005","journal-title":"CCP4 Newsl."},{"key":"10.1016\/j.ejmech.2022.114105_bib44","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.ejmech.2022.114105_bib45","first-page":"8","article-title":"The Phenix refinement framework","volume":"42","author":"Afonine","year":"2005","journal-title":"CCP4 Newsl."},{"key":"10.1016\/j.ejmech.2022.114105_bib46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S2059798317000067","article-title":"AceDRG: a stereochemical description generator for ligands","volume":"73","author":"Long","year":"2017","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.ejmech.2022.114105_bib47","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1107\/S1399004714028132","article-title":"FEM: feature-enhanced map","volume":"71","author":"Afonine","year":"2015","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.ejmech.2022.114105_bib48","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1107\/S2059798316018210","article-title":"Polder maps: improving OMIT maps by excluding bulk solvent","volume":"73","author":"Liebschner","year":"2017","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.ejmech.2022.114105_bib49","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.ejmech.2022.114105_bib50","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1432-1327.1998.2570577.x","article-title":"Characterisation of flavodoxin NADP+ oxidoreductase and flavodoxin; key components of electron transfer in Escherichia coli","volume":"257","author":"McIver","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejmech.2022.114105_bib51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/bj3520257","article-title":"Probing the NADPH-binding site of Escherichia coli flavodoxin oxidoreductase","volume":"352","author":"Leadbeater","year":"2000","journal-title":"Biochem. J."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342200006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342200006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:38:43Z","timestamp":1759329523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342200006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":51,"alternative-id":["S022352342200006X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114105","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114105"}}